Sterling Biotech to raise funds through NCD issue

Sterling Biotech Ltd has announced that the Board of Directors of the Company at its meeting held on June 25, 2008, inter alia, has approved issue of secured Non Convertible Debentures (NCD) on private placement basis to the extent of Rs 300 Crores on such terms and conditions as may be mutually agreed upon with the lenders / subscribers of the NCDs in compliance with the Guidelines issued by SEBI and other regulatory requirements for issue of Debentures.

Source : Equity Bulls

Keywords